![Wissenschaftliches Bild](/system/files/styles/mdc_list_teaser_mdc_mobile_1_5x/private/2024-07/MDC_Okt%202017_3314_0.jpg?h=2fe4426f&itok=l7e6Bryz)
Sharpening the gene scissors together
The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from Nice have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for genetically determined diseases.